Cyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysis

BACKGROUND: Esophageal adenocarcinoma (EAC) has high mortality and is increasing in incidence. Barrett's esophagus (BE) increases the risk for EAC. Studies have reported inconsistent findings on the association between use of cyclooxygenase (COX) inhibitors and the risk of neoplastic progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, S, Zhang, X-Q, Ding, X-W, Yang, R-K, Huang, S-L, Kastelein, F, Bruno, M, Yu, X-J, Zhou, D, Zou, X-P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007227/
https://www.ncbi.nlm.nih.gov/pubmed/24651385
http://dx.doi.org/10.1038/bjc.2014.127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007227/
https://www.ncbi.nlm.nih.gov/pubmed/24651385
http://dx.doi.org/10.1038/bjc.2014.127

Ejemplares similares